# Digital PCR Market Report: Size, Share & Trends 2026-2035

> The Global Digital PCR market was valued at USD 1,843.6 Mn in 2025 and will reach USD 5,206.5 Mn by 2035, a 10.94% CAGR. Instruments hold 44.0% of revenue today, but reagents and consumables overtake them by 2035. North America leads with 41.0%. Oncology testing is the largest application, and infectious disease testing grows fastest at 14.58% a year.

- Publisher: Vectomat Insights
- Report code: VMI-1-3-97529
- Published: 2026-11-15
- Canonical URL: https://www.vectomatinsights.com/report/digital-pcr-market
- Base year 2025: USD 1,843.6 Mn
- Forecast 2035: USD 5,206.5 Mn
- CAGR 2026–2035: 10.94%

## Key insights

- The Global Digital PCR market rises from USD 1,843.6 Mn in 2025 to USD 5,206.5 Mn by 2035, a 10.94% CAGR over 2026–2035, roughly 2.8 times its base-year size.
- Instruments are the largest product line at 44.0% of 2025 revenue (USD 811.2 Mn), but they compound at only 7.0% a year; reagents and consumables (USD 774.3 Mn) grow at 11.92% and become the biggest line, at USD 2,387.4 Mn, by 2035.
- Software & Services is the fastest-growing product category at a 16.84% CAGR, climbing from USD 258.1 Mn to USD 1,224.0 Mn as labs buy analysis software and service contracts alongside the box.
- Droplet digital PCR dominates the technology mix with 61.6% of 2025 revenue (USD 1,136.2 Mn); nanoplate-based, microfluidic and BEAMing formats are the fastest-growing at a 16.62% CAGR.
- Oncology testing is the largest application at 34.0% (USD 626.8 Mn), while infectious disease testing grows fastest at 14.58% a year and becomes the largest application, at USD 2,156.3 Mn, by 2035.
- Diagnostic laboratories hold 42.5% of 2025 revenue; pharma and biotech companies are the fastest-growing end user at a 15.59% CAGR on cell and gene therapy quality-control demand.
- North America leads with 41.0% of 2025 revenue (USD 755.9 Mn), and the United States alone accounts for USD 619.8 Mn; Asia Pacific is the fastest-growing region, with South Korea compounding at 13.1% a year.
- Consolidation is redrawing the vendor map: Bio-Rad bought Stilla Technologies for about USD 225 Mn in June 2025, Roche agreed to buy SAGA Diagnostics for up to USD 595 Mn in April 2026, and EQT agreed a EUR 10.8 Bn take-private of QIAGEN in October 2026.
- QIAGEN reported more than 3,200 cumulative QIAcuity placements in June 2026, with over 400 customers running multiple instruments.

## Figures

![Digital PCR market size — USD 1,843.6 Mn (2025) to USD 5,206.5 Mn (2035), 10.94% CAGR | Vectomat Insights](https://vectomat-media-prod.tor1.cdn.digitaloceanspaces.com/reports/digital-pcr-market/8ed8e6c8a325739c/digital-pcr-market-size-vmi.png) — The Global Digital PCR Market grows from USD 1,843.6 Mn in 2025 to USD 5,206.5 Mn by 2035, a 10.94% CAGR. Source: Vectomat Insights, Digital PCR Market Report.
![Digital PCR market drivers, restraints, opportunities and challenges | Vectomat Insights](https://vectomat-media-prod.tor1.cdn.digitaloceanspaces.com/reports/digital-pcr-market/8ed8e6c8a325739c/digital-pcr-market-droc-vmi.png) — Liquid Biopsy and MRD Monitoring and wastewater and outbreak surveillance drive the Digital PCR Market, while academic funding and capex pressure restrains it. Source: Vectomat Insights, Digital PCR Market Report.
![Digital PCR market share by region 2025 — North America leads at 41.0% | Vectomat Insights](https://vectomat-media-prod.tor1.cdn.digitaloceanspaces.com/reports/digital-pcr-market/8ed8e6c8a325739c/digital-pcr-market-regional-share-vmi.png) — North America holds 41.0% of the 2025 Digital PCR Market, and Asia Pacific is the fastest-growing region. Source: Vectomat Insights, Digital PCR Market Report.
![Digital PCR market segmentation overview — dominant sub-segments by dimension, 2025 | Vectomat Insights](https://vectomat-media-prod.tor1.cdn.digitaloceanspaces.com/reports/digital-pcr-market/8ed8e6c8a325739c/digital-pcr-market-segments-vmi.png) — Dominant sub-segments in 2025: Instruments (Product), Oncology Testing (Application), Droplet Digital PCR (Technology), Diagnostic Laboratories (End User). Source: Vectomat Insights, Digital PCR Market Report.
![Digital PCR market share by application 2025 — Oncology Testing 34.0% | Vectomat Insights](https://vectomat-media-prod.tor1.cdn.digitaloceanspaces.com/reports/digital-pcr-market/8ed8e6c8a325739c/digital-pcr-market-application-share-vmi.png) — Oncology Testing leads the Digital PCR Market by application with 34.0% of 2025 revenue. Source: Vectomat Insights, Digital PCR Market Report.
![Digital PCR market share by technology 2025 — Droplet Digital PCR 61.6% | Vectomat Insights](https://vectomat-media-prod.tor1.cdn.digitaloceanspaces.com/reports/digital-pcr-market/8ed8e6c8a325739c/digital-pcr-market-technology-share-vmi.png) — Droplet Digital PCR leads the Digital PCR Market by technology with 61.6% of 2025 revenue. Source: Vectomat Insights, Digital PCR Market Report.
![Digital PCR market technology mix by region — North America, Europe, Asia Pacific | Vectomat Insights](https://vectomat-media-prod.tor1.cdn.digitaloceanspaces.com/reports/digital-pcr-market/8ed8e6c8a325739c/digital-pcr-market-regional-segments-vmi.png) — Droplet systems carry 65.0% of North American digital PCR revenue, against 58.5% in Asia Pacific, where chip-based platforms take a larger share. Source: Vectomat Insights, Digital PCR Market Report.
![Digital PCR market competitive landscape — positioning of 10 key companies | Vectomat Insights](https://vectomat-media-prod.tor1.cdn.digitaloceanspaces.com/reports/digital-pcr-market/8ed8e6c8a325739c/digital-pcr-market-competitive-landscape-vmi.png) — Bio-Rad Laboratories, QIAGEN, Roche and Thermo Fisher Scientific combine the broadest installed bases with the deepest clinical workflows, while Korean specialists and Countable Labs compete on price and sensitivity. Source: Vectomat Insights, Digital PCR Market Report.
![Digital PCR market at a glance — USD 1,843.6 Mn in 2025, 10.94% CAGR to 2035 | Vectomat Insights](https://vectomat-media-prod.tor1.cdn.digitaloceanspaces.com/reports/digital-pcr-market/8ed8e6c8a325739c/digital-pcr-market-key-numbers-vmi.png) — The Digital PCR Market was worth USD 1,843.6 Mn in 2025, led by North America and Droplet Digital PCR. Source: Vectomat Insights, Digital PCR Market Report.
![United States Digital PCR market size — USD 619.8 Mn (2025) to USD 1,564.3 Mn (2035) | Vectomat Insights](https://vectomat-media-prod.tor1.cdn.digitaloceanspaces.com/reports/digital-pcr-market/8ed8e6c8a325739c/digital-pcr-market-united-states-snapshot-vmi.png) — The United States Digital PCR Market rises from USD 619.8 Mn in 2025 to USD 1,564.3 Mn by 2035 at a 9.7% CAGR. Source: Vectomat Insights, Digital PCR Market Report.
![Germany Digital PCR market size — USD 119.5 Mn (2025) to USD 290.8 Mn (2035) | Vectomat Insights](https://vectomat-media-prod.tor1.cdn.digitaloceanspaces.com/reports/digital-pcr-market/8ed8e6c8a325739c/digital-pcr-market-germany-snapshot-vmi.png) — The Germany Digital PCR Market rises from USD 119.5 Mn in 2025 to USD 290.8 Mn by 2035 at a 9.3% CAGR. Source: Vectomat Insights, Digital PCR Market Report.
![South Korea Digital PCR market size — USD 92.9 Mn (2025) to USD 318.2 Mn (2035) | Vectomat Insights](https://vectomat-media-prod.tor1.cdn.digitaloceanspaces.com/reports/digital-pcr-market/8ed8e6c8a325739c/digital-pcr-market-south-korea-snapshot-vmi.png) — The South Korea Digital PCR Market rises from USD 92.9 Mn in 2025 to USD 318.2 Mn by 2035 at a 13.1% CAGR. Source: Vectomat Insights, Digital PCR Market Report.

## Market size (USD million)

| Year | Value |
|---|---|
| 2023 | 1,536.0 |
| 2024 | 1,678.4 |
| 2025 | 1,843.6 |

## Share by Product (2025)

| Segment | Share | USD Mn |
|---|---|---|
| Instruments | 44% | 811.2 |
| Reagents & Consumables | 42% | 774.3 |
| Software & Services | 14% | 258.1 |

## Share by Application (2025)

| Segment | Share | USD Mn |
|---|---|---|
| Oncology Testing | 34% | 626.8 |
| Infectious Disease Testing | 30% | 553.1 |
| Genetic Disease Testing | 20% | 368.7 |
| Prenatal & Reproductive Testing and Transplant Monitoring | 16% | 295.0 |

## Share by Technology (2025)

| Segment | Share | USD Mn |
|---|---|---|
| Droplet Digital PCR | 61.6% | 1,136.2 |
| Chip-Based Digital PCR | 30.4% | 559.9 |
| Nanoplate-based & microfluidic digital PCR and BEAMing | 8% | 147.5 |

## Share by End User (2025)

| Segment | Share | USD Mn |
|---|---|---|
| Diagnostic Laboratories | 42.5% | 783.8 |
| Academic & Research Institutes | 31.5% | 580.5 |
| Pharma & Biotech Companies | 26% | 479.3 |

## Regional share

| Region | Share | USD Mn |
|---|---|---|
| North America | 41% | 755.9 |
| Europe | 24.74% | 456.2 |
| Asia Pacific | 23.81% | 439.0 |
| Latin America | 5% | 92.2 |
| The Middle East | 3.07% | 56.6 |
| Africa | 2.38% | 43.8 |

## Key companies

- Bio-Rad Laboratories (United States): Droplet Digital PCR systems (QX200, QX600, QX Continuum, QX700 series), ddPCR reagents and FDA-cleared QXDx clinical kits
- QIAGEN (Netherlands): QIAcuity nanoplate dPCR systems, QIAcuityDx clinical platform, GeneGlobe assays and CGT quality-control kits
- Thermo Fisher Scientific (United States): QuantStudio Absolute Q microfluidic-array dPCR system, Absolute Q AutoRun automation suite and TaqMan-based dPCR assays
- Roche (Switzerland): Digital LightCycler dPCR system for oncology, transplant and infectious disease testing
- Stilla Technologies (France): Crystal digital PCR and the Nio family of high-multiplex, all-in-one systems, now sold as Bio-Rad's QX700 series
- Countable Labs (United States): Countable PCR, a single-molecule counting platform using about 30 million partitions in a gel matrix
- Biodesix (United States): ddPCR-based lung and breast cancer tests and assay development services from its CLIA-CAP laboratory
- SAGA Diagnostics (Sweden): Pathlight tumour-informed MRD test combining whole-genome sequencing with digital PCR, plus SAGAsafe dPCR assays
- GENCURIX (South Korea): Oncology and methylation-based dPCR liquid biopsy assays
- BioTNS (South Korea): LQ Suite microdroplet digital PCR platform and blood cancer liquid biopsy kits
- Revosketch (South Korea): digiQuark microwell-disc digital PCR for cancer mutation detection
- Hamilton Company (United States): Liquid-handling automation that loads and processes QIAcuity dPCR plates

## FAQs

### What does the VMI Digital PCR market report include?

The report includes market sizing for 2023–2025 and forecasts to 2035 across 4 segmentation dimensions: product, application, technology and end user. It covers 6 regions and 35+ countries, a production and volume analysis of systems installed, 12 company profiles, a full drivers-restraints-opportunities-challenges framework, recent developments and a detailed table of contents with 98 tables and 72 figures, according to Vectomat Insights.

### How big is the digital PCR market by technology?

Droplet digital PCR generated USD 1,136.2 Mn in 2025, a 61.6% share, and grows at 11.76% a year. Chip-based digital PCR contributed USD 559.9 Mn, or 30.4%, growing at 6.64%. Nanoplate-based, microfluidic and BEAMing formats are the smallest group at USD 147.5 Mn but the fastest-growing at a 16.62% CAGR, reaching USD 686.3 Mn by 2035, according to Vectomat Insights.

### Which product category grows fastest in digital PCR?

Software & Services is the fastest-growing product category at a 16.84% CAGR, rising from USD 258.1 Mn in 2025 to USD 1,224.0 Mn in 2035. Reagents and consumables, at 11.92% a year, overtake instruments as the largest line and reach USD 2,387.4 Mn. Instruments still hold 44.0% of 2025 revenue but grow at 7.0%, according to Vectomat Insights.

### How large is the U.S. digital PCR market?

The United States digital PCR market was worth USD 619.8 Mn in 2025, up from USD 515.0 Mn in 2023, and is forecast to grow at a 9.7% CAGR to about USD 1,564.3 Mn by 2035. It accounts for most of North America's USD 755.9 Mn, supported by CDC wastewater surveillance and clinical oncology testing, according to Vectomat Insights.

### Which end user segment grows fastest in digital PCR?

Pharma and biotech companies grow fastest, at a 15.59% CAGR from USD 479.3 Mn in 2025 to USD 2,041.2 Mn in 2035, driven by vector titre and residual DNA testing for cell and gene therapies. Diagnostic laboratories remain the largest end user at 42.5% of 2025 revenue, while academic institutes grow slowest at 5.92%, according to Vectomat Insights.

### How is consolidation changing the digital PCR market?

Three deals in 16 months reshaped the vendor base. Bio-Rad acquired Stilla Technologies for about USD 225 Mn in June 2025, Roche agreed to buy SAGA Diagnostics for up to USD 595 Mn in April 2026, and EQT agreed to take QIAGEN private for about EUR 10.8 Bn in October 2026. Each deal adds platforms, clinical tests or long-term investment capacity, according to Vectomat Insights.

### How did VMI estimate the digital PCR market?

VMI combined a bottom-up model, built from the installed base of dPCR systems and consumable pull-through per system, with a top-down check against vendor revenue. Inputs include interviews with laboratory directors and quality-control managers, company filings, FDA and IVDR records and CDC publications. Segment, regional and country values were reconciled to the USD 1,843.6 Mn base year, according to Vectomat Insights.

Cite as: Vectomat Insights (2026). Digital PCR Market Report. https://www.vectomatinsights.com/report/digital-pcr-market